The Urogynecology Section of the Polish Society of Gynecologists and Obstetricians Guideline on the use of urodynamic testing in gynecological practice.

bladder outlet obstruction guidelines overactive bladder stress urinary incontinence urodynamics voiding dysfunction

Journal

Ginekologia polska
ISSN: 2543-6767
Titre abrégé: Ginekol Pol
Pays: Poland
ID NLM: 0374641

Informations de publication

Date de publication:
2021
Historique:
received: 31 03 2021
accepted: 31 03 2021
entrez: 12 4 2021
pubmed: 13 4 2021
medline: 24 3 2022
Statut: ppublish

Résumé

The aim was to present an interdisciplinary Guideline of the Urogynecology Section of the Polish Society of Gynecologists and Obstetricians (PSGO) for the use of urodynamics (UDS) in the diagnostic process of patients with lower urinary tract symptoms (LUTS) based on the available literature, expert knowledge, and everyday practice. A review of the literature concerning the use of UDS in women, including current international guidelines and earlier recommendations of the PSGO Urogynecology Section, was conducted. Urodynamic testing allows to make the urodynamic diagnosis which, nevertheless, remains to be the preliminary diagnosis. Medical history, physical examination, and detailed analysis of the previous test results (laboratory, imaging, endoscopic) need to be taken into consideration before making the final diagnosis. Urodynamic testing before surgical treatment of SUI is allowable, but the decision remains at the discretion of the physician. Urodynamic testing is not necessary before primary surgical treatment of uncomplicated SUI, but it has been demonstrated to optimize the therapeutic methods in complicated SUI. The significance of UDS in the diagnostic process of patients with overactive bladder symptoms, voiding dysfunction, and bladder outlet obstruction was discussed. Urodynamic testing is a vital element of the urogynecological diagnostic process. The scope of UDS should reflect the individual needs and symptoms of each patient and be based on the current guidelines, expert knowledge and experience of the physician, indications, and eligibility, as well as additional test results of the affected patients. Due to formal and legal requirements, PSGO, in this Guideline, wishes to emphasize the need for an individualized approach to both, test performance and result interpretation.

Identifiants

pubmed: 33844242
pii: VM/OJS/J/75881
doi: 10.5603/GP.2021.0045
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-235

Auteurs

Artur Rogowski (A)

Department of Gynecology, "Inflancka" Specialist Hospital, Warsaw, Poland. edytawlazlak@gmail.com.
Cardinal Stefan Wyszynski University in Warsaw, Faculty of Medicine, Collegium Medicum, Warsaw, Poland. edytawlazlak@gmail.com.
Department of Obstetrics and Gynecology, Mother and Child Institute, Warsaw, Poland. edytawlazlak@gmail.com.

Bartosz Dybowski (B)

Department of Urology, Roefler Memorial Hospital, Pruszkow, Poland.

Edyta Wlazlak (E)

Department of Operative Gynecology and Gynecological Oncology, I Department of Gynecology and Obstetrics, Medical University of Lodz, Poland.

Wlodzimierz Baranowski (W)

Department of Gynecology and Oncological Gynecology Military Institute of Medicine, Warsaw, Poland.

Tomasz Rechberger (T)

II Department of Gynecology, Medical University of Lublin, Poland.

Klaudia Stangel-Wojcikiewicz (K)

Jagiellonian University Medical College, Department of Gynecology and Oncology, Cracow, Poland.

Magdalena E Grzybowska (ME)

Department of Gynecology, Gynecological Oncology and Gynecological Endocrinology, Medical University of Gdansk, Poland.

Tomasz Kluz (T)

Department of Gynecology and Obstetrics, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.

Elzbieta Narojczyk-Swiesciak (E)

II Department of Obstetrics and Gynecology Centre of Postgraduate Medical Education Bielański Hospital, Warsaw, Poland.

Monika Szafarowska (M)

Department of Gynecology and Oncological Gynecology Military Institute of Medicine, Warsaw, Poland.

Zofia Rozpendowska (Z)

Department of Operative Gynecology and Gynecological Oncology, I Department of Gynecology and Obstetrics, Medical University of Lodz, Poland.

Grzegorz Surkont (G)

Department of Operative Gynecology and Gynecological Oncology, I Department of Gynecology and Obstetrics, Medical University of Lodz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH